10-Q: Centrus Energy Corp. Reports Strong Q1 2025 Results, Fueled by Increased SWU Revenue
Quarterly Report
Centrus Energy Corp. announces a significant increase in revenue and net income for the first quarter of 2025, driven by higher separative work unit (SWU) sales and prices.
Summary
- Centrus Energy Corp. reported a net income of $27.2 million for the three months ended March 31, 2025, compared to a net loss of $6.1 million for the same period in 2024.
- Revenue increased to $73.1 million, up from $43.7 million in the prior year, primarily due to higher SWU sales and prices.
- The LEU segment saw a substantial increase in gross profit, rising to $31.2 million from $0.5 million year-over-year.
- The Technical Solutions segment experienced a decrease in gross profit, falling to $1.7 million from $3.8 million.
- The company redeemed all of its 8.25% Notes in March 2025, resulting in a gain of $11.8 million.
- Centrus is actively pursuing opportunities to expand its uranium enrichment capacity, including potential deployment of LEU enrichment alongside HALEU enrichment.
- The company is managing its working capital to improve the long-term value of its LEU and Technical Solutions businesses.
- Centrus is monitoring the impact of the war in Ukraine, the Import Ban Act, and the Russian Decree on its supply chain and operations.
- The company is seeking waivers from the DOE to allow continued importation of LEU from Russia.
- Centrus was awarded a time and materials task order with a total award ceiling of approximately $0.5 million under the LEU Production Contract.
- The company is investing approximately $60.0 million over an 18-month period to expand its manufacturing capacity in Oak Ridge, Tennessee.
- The IRS granted Centrus a $62.4 million credit allocation for its manufacturing facility in Oak Ridge.
- The company submitted a response to a Request for Information (RFI) from the DOEs National Nuclear Security Administration (NNSA) for an AC100 Deployment Demonstration.
Sentiment
Score: 8
Explanation: The document presents a positive outlook with strong financial results, strategic initiatives, and government support. However, risks related to geopolitical factors and regulatory uncertainties temper the overall sentiment.
Positives
- Significant increase in revenue and net income driven by higher SWU sales and prices.
- Successful redemption of 8.25% Notes, resulting in a gain of $11.8 million.
- Expansion of manufacturing capacity in Oak Ridge, Tennessee, supported by a $62.4 million credit allocation from the IRS.
- Strong backlog of $3.8 billion providing revenue visibility through 2040.
- Award of a $0.5 million task order under the LEU Production Contract.
- The IRS granted Centrus a $62.4 million credit allocation for its manufacturing facility in Oak Ridge.
Negatives
- Gross profit decreased in the Technical Solutions segment, falling to $1.7 million from $3.8 million.
- The company faces risks related to the war in Ukraine, the Import Ban Act, and the Russian Decree, which could impact its supply chain and operations.
- Uncertainty remains regarding the timing and amount of task orders that may be issued under the HALEU Production Contract, LEU Production Contract, or HALEU Deconversion Contract.
- The company is unable to achieve delivery of the 900 kilograms of HALEU UF6 for Phase 2 by November 2024.
Risks
- The war in Ukraine and related sanctions could disrupt the supply of LEU from Russia.
- The Import Ban Act could restrict the import of LEU from Russia, impacting the company's ability to meet customer demand.
- The Russian Decree could limit the export of LEU from Russia, affecting the company's supply chain.
- Delays in government funding or changes in government policy could impact the company's contracts and operations.
- The company faces competition from other LEU producers.
- The company is unable to achieve delivery of the 900 kilograms of HALEU UF6 for Phase 2 by November 2024.
- The U.S. ban on imports of Russian LEU, without the grant of additional timely waivers, would have a negative material impact on our business.
Future Outlook
Centrus is focused on expanding its uranium enrichment capacity to meet government and commercial requirements, deploying LEU enrichment alongside HALEU enrichment, and exploring strategic partnerships. The company is also seeking public and private funding to deploy new production capacity at its Piketon, Ohio, plant.
Management Comments
- The company is committed to the restoration of Americas domestic uranium enrichment production capability in order to play a critical role in meeting U.S. national security and energy security requirements and advancing Americas nonproliferation, energy, and climate objectives.
- The company's goal is to deliver major components of the next-generation nuclear fuels that will provide reliable carbon-free power around the world.
Industry Context
The global nuclear industry outlook has improved, driven by the development of advanced reactors, innovation of advanced fuel types, and commitment of nations to deploy or increase nuclear power. The war in Ukraine has created uncertainty in the uranium market, leading to higher prices and calls for investment in domestic enrichment capacity.
Comparison to Industry Standards
- The report mentions that Russian enrichment plants represent 44% of the world's capacity, highlighting the significant role Russia plays in the global uranium enrichment market.
- The report references data from the World Nuclear Association (WNA) indicating that the annual enrichment requirements of reactors worldwide outside of Russia vastly exceeds the available supply of non-Russian enrichment.
- The report mentions URENCO USA (f/k/a Louisiana Energy Services Inc. (LES)), Orano Cycle, Orano USA, Urenco Ltd., Urenco, Inc., LIS Technologies Inc., General Matter, Inc., TENEX, GLE (Global Laser Enrichment), Cameco, and any subsidiary or affiliate thereof engaged in a business that is competitive with the uranium enrichment and deconversion business conducted by the Company or any of its affiliated companies, and any contractor or subcontractor to any of these businesses (with respect to activities by such contractor or subcontractor that are competitive with the uranium enrichment business conducted by the Company or any of its affiliated companies).
Legal Proceedings
- The Company is assessing DOEs assertions including whether all or a portion of any such potential liability had been previously settled.
- The Company believes that its operations at the Portsmouth GDP site were fully in compliance with the NRCs regulations.
- Further, the Company and Enrichment Corp. believe that any such liability should be indemnified under the Price-Anderson Act.
- The Company and Enrichment Corp. have provided notifications to DOE required to invoke indemnification under the Price-Anderson Act and other contractual provisions.
Stakeholder Impact
- Shareholders: Positive impact due to increased revenue, net income, and strategic initiatives.
- Employees: Potential for job growth and stability due to expansion of operations.
- Customers: Continued supply of nuclear fuel components and potential for new products and services.
- Suppliers: Opportunities for increased business due to expansion of operations.
- Communities: Positive economic impact due to job creation and investment in local facilities.
Next Steps
- Continue to pursue waivers from the DOE to allow continued importation of LEU from Russia.
- Continue to monitor the impact of the war in Ukraine, the Import Ban Act, and the Russian Decree on its supply chain and operations.
- Continue to pursue opportunities to expand its uranium enrichment capacity, including potential deployment of LEU enrichment alongside HALEU enrichment.
- Continue to seek public and private funding to deploy new production capacity at its Piketon, Ohio, plant.
Key Dates
| Date | Description |
|---|---|
| 2011 | Fukushima accident in Japan led to decline in SWU spot prices. |
| 2015 | Modification to TENEX Supply Contract allowing rescheduling of SWU quantities. |
| 2018 | SWU spot prices bottomed out at $34 per SWU. |
| 2018 | Centrus entered into the Orano Supply Agreement. |
| 2019 | Centrus signed the HALEU Demonstration Contract with the DOE. |
| November 10, 2022 | DOE awarded the HALEU Operation Contract to Centrus. |
| December 1, 2022 | Work began on the HALEU Operation Contract. |
| November 7, 2023 | Centrus announced its first delivery of HALEU to the DOE. |
| November 2023 | Centrus transitioned to Phase 2 of the HALEU Operation Contract. |
| October 4, 2024 | DOE selected ACO and five other awardees under the HALEU deconversion solicitation. |
| October 16, 2024 | DOE selected ACO and three other awardees under the HALEU production solicitation. |
| November 5, 2024 | HALEU Operation Contract was modified to extend the Phase 2 period of performance to June 30, 2025. |
| November 6, 2024 | DOE issued requests for task order proposals under the HALEU Deconversion Contract and the HALEU Enrichment Contracts. |
| November 7, 2024 | Centrus issued 2.25% Convertible Notes with an aggregate principal amount of $402.5 million. |
| November 14, 2024 | The government of the Russian Federation passed the Russian Decree, effective through December 31, 2025. |
| November 20, 2024 | Centrus announced the resumption of centrifuge manufacturing activities and the expansion of its manufacturing capacity in Oak Ridge, Tennessee. |
| December 10, 2024 | DOE selected ACO and five other awardees under the LEU production solicitation. |
| December 20, 2024 | The DOEs National Nuclear Security Administration (NNSA) announced that it had released a Request for Information (RFI) for industry input on an AC100 Deployment Demonstration. |
| January 9, 2025 | Centrus submitted its proposals in response to requests for task order proposals under the HALEU Deconversion Contract and the HALEU Enrichment Contracts. |
| January 10, 2025 | The IRS granted Centrus a $62.4 million credit allocation for its manufacturing facility in Oak Ridge. |
| January 20, 2025 | Executive Order 14154, issued on January 20, 2025, directed executive agencies of the U.S. federal government to pause the distribution of federal funding. |
| February 4, 2025 | Centrus submitted its response to the RFI from the DOEs National Nuclear Security Administration (NNSA) for an AC100 Deployment Demonstration. |
| February 24, 2025 | Centrus issued a notice of redemption for all 8.25% Notes. |
| March 26, 2025 | Centrus redeemed all 8.25% Notes. |
| March 30, 2025 | The Company submitted its proposal in response to a request for task order from the DOE for a report and additional deliverables under the LEU Production Contract. |
| March 31, 2025 | The Court did not grant our motion to dismiss the Complaint for being time-barred. |
| April 11, 2025 | The Company was awarded a time and materials task order with a total award ceiling of approximately $0.5 million. |
| April 15, 2025 | The President of the United States signed an Executive Order initiating a Department of Commerce investigation under Section 232 of the Trade Expansion Act of 1962. |
| April 17, 2025 | The Office of the United States Trade Representative (USTR) released a notice issuing the results of its investigation into Chinas dominance in the maritime, logistics, and shipbuilding sectors pursuant to Section 302(a) of the Trade Act of 1974, as amended. |
| May 1, 2025 | There were 16,318,066 shares of the registrants Class A Common Stock, par value $0.10 per share, and 719,200 shares of the registrants Class B Common Stock, par value $0.10 per share, outstanding. |
| May 5, 2025 | Modification 19 to Agreement, dated May 5, 2025, by and between American Centrifuge Operating, LLC and the U.S. Department of Energy. |
| May 8, 2025 | Date of the filing of the quarterly report on Form 10-Q. |
| May 28, 2024 | The Company entered into a Sixth Amendment to the Section 382 Rights Agreement. |
Keywords
HALEU, LEU, SWU, Centrus Energy, Uranium Enrichment, Nuclear Fuel, Technical Solutions, American Centrifuge, DOE, Import Ban Act, Russian Decree
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.